Sector portfolio · Corporate investor · United States
Merck Global Health Innovation Fund's Biotech portfolio
Merck Global Health Innovation Fund has backed 15 Biotech startups in rounds we track, $3.7B between them, shown by the stage each has reached. The best-funded is Grail.
Funding by segment
- Series C and later$1.6B8
- Series B$1.9B4
- Stage not reported$256M3
Where they are based
- United States14$3.7B
- Switzerland1$8.0M
United States
SwitzerlandFounded
3 without a founding year on record.
Total raised
- Under $1M0
- $1M to $10M2
- $10M to $50M4
- $50M to $250M6
- $250M to $1B2
- $1B and over1
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
12 of 15 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States14
- Switzerland1
Startups by country, 2 countries in all.
Segment by segment
Series C and later
8 startups · $1.6B raised
ModernaLearn how we’re changing the world of medicine.United States$675M
PathAIPathAI develops technology that assists pathologists in making accurate diagnoses for every patient, every time.United States$400M
LifeMine TherapeuticsLifeMine Therapeutics combines genomics with AI and synthetic biology to discover and develop a pipeline of novel medicines.United States$230M
VisterraVisterra researches on and develops therapeutic and diagnostic products for the treatment of infectious diseases.United States$120M
ClearDATAClearDATA is a cloud compliance and security solution designed specifically for the healthcare industry.United States$80M
eHealth Technologies™eHealth Technologies is a healthcare technology company based in West Henrietta, New York, founded in 2006.United States$50M
SyapseSyapse is a real-world evidence company dedicated to extinguishing the fear and burden of serious disease by advancing real-world United States$45M- PPrgnosUnited States$21M
Series B
4 startups · $1.9B raised
- GGrailUnited States$1.6B
ElectroCoreElectroCore develops neuromodulation therapies for the non-invasive treatment of diseases and disorders.United States$121M- IBImago BioSciencesImago is a clinical stage biopharmaceutical company that develops drugs for the management of proliferative diseases of the bone marrow.United States$67M
Atropos HealthAtropos Health is a healthcare technology company founded in 2020, evolving from Stanford University’s “Green Button” project.United States$33M
Stage not reported
3 startups · $256M raised
TriNetXTriNetX is a health research network that connects drug discovery and development from pharmaceutical companies.United States$240M
VaximmVAXIMM is a vaccine company offers VXM01 targeting tumor vasculature.Switzerland$8.0M- SSerlImmuneUnited States$8.0M
How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Merck Global Health Innovation Fund as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosRaising from investors like Merck Global Health Innovation Fund?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.